JPS5913955A - Method for measuring lectin juvenilization - Google Patents

Method for measuring lectin juvenilization

Info

Publication number
JPS5913955A
JPS5913955A JP12327982A JP12327982A JPS5913955A JP S5913955 A JPS5913955 A JP S5913955A JP 12327982 A JP12327982 A JP 12327982A JP 12327982 A JP12327982 A JP 12327982A JP S5913955 A JPS5913955 A JP S5913955A
Authority
JP
Japan
Prior art keywords
lectin
intensity
fluorescence
lymphocytes
lymphocyte
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP12327982A
Other languages
Japanese (ja)
Inventor
Isamu Fukamachi
勇 深町
Shoichi Adachi
正一 足立
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NIPPON KOUTAI KENKYUSHO KK
Original Assignee
NIPPON KOUTAI KENKYUSHO KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NIPPON KOUTAI KENKYUSHO KK filed Critical NIPPON KOUTAI KENKYUSHO KK
Priority to JP12327982A priority Critical patent/JPS5913955A/en
Publication of JPS5913955A publication Critical patent/JPS5913955A/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

PURPOSE:To determine simply and exactly juvenilization, by culturing lymphocyte with the addition of lectin, adding ethidium bromide to the cultured liquid to allow both to react, and measuring the intensity of emitted fluorescent. CONSTITUTION:Heparin-added peripheral blood is diluted with a phosphoric acid buffer solution. Lumphocyte is prepared by collecting a mononuclear layer with a specific-gravity centrifugal method, etc., and phytohemagglutinin, peanut agglutinin, etc. are added to said lymphocyte. Culturing is carried out at about 37 deg.C for 72hr by the use of modified RPMI-1640, MEM, etc. as a medium. Obtained lectin-treated lymphocyte is dissolved by using sodium lauryl sulfate (SDB), etc., and ethidium bromide (EB) is added thereto to allow both to react. The intensity of fluorescence I0 of EB plus SDS, the intensity of fluorescence I1 of EB plus untreated lumphocytes, and the intensity of fluorescence of EB plus SDS plus lectin-treated lymphocytes are measured. Then the increasing ratio of DNA is obtained according to the equation of (I2-I0)/(I1-I0) to determine lectin- induced junvenilization. Since this method is based on the measurement of intensity of fluorescence of EB and DNA complex, no errors due to different conductors occur, and no effect of the number of lymphocytes appears within a range from 0.5X10<6> to 1.5X10<6> per ml. In addition, the procedure is simple.

Description

【発明の詳細な説明】 本発明はレクチン幼若化測定法に関する。[Detailed description of the invention] The present invention relates to a method for measuring lectin rejuvenation.

ノウ、=c /l/ (Novell )によって、1
960年インゲンマメの抽出液がリンパ球の幼若化、細
胞分裂促進作用を有することが報告(0ancer R
θS。
Nou, = c /l/ (Novell), 1
In 1960, it was reported that kidney bean extract had the effect of stimulating lymphocytes and promoting cell division (0ancer R
θS.

20.462〜466.1960)されて以来、多くの
植物性細胞凝集素(レクチン)が見出されている。そし
て、これらレクチンはリンパ球を非特異的に活性化する
とされており、リンパ球にレクチンを添加すると1時間
以内に細胞代謝活性の変化が起り、次に蛋白合成、DN
A合成の増大が起る。
20.462-466.1960), many plant cell agglutinins (lectins) have been discovered since then. These lectins are said to non-specifically activate lymphocytes, and when lectins are added to lymphocytes, changes in cellular metabolic activity occur within an hour, followed by protein synthesis and DNA synthesis.
An increase in A synthesis occurs.

一方、レクチンに対するリンパ球の幼若化(リンパ球反
応)は、癌疾患等によって低−ドするので、レクチンに
よる幼若化を測定すれば、癌疾患及びその進行度を検査
することができる。
On the other hand, since the immaturity of lymphocytes (lymphocyte reaction) against lectins is reduced by cancer diseases, etc., cancer diseases and their progression can be examined by measuring the immaturity caused by lectins.

現在、このレクチンによる幼若化の測定法としては、形
態学的な観察による方法と、放射性物質の取り込みを液
体シンチレーションカウンターで測定する方法とが行な
われている。前者については、熟練を要し、後者につい
ては放射性物質を扱うため特殊な設備が必要となり、ま
だ結果の判定に苦慮するのが現状であるだめ、有用な検
査であるにもかかわらず、−膜化されていない。
Currently, methods for measuring juvenile development using this lectin include morphological observation and measurement of radioactive substance uptake using a liquid scintillation counter. The former requires skill, and the latter requires special equipment to handle radioactive materials, and it is still difficult to judge the results. has not been standardized.

そこで本発明者は、斯かる欠点を克服せんと企画シ、エ
チジウム・ブロマイド(以下、lf BJと称する)は
、それ自体では螢光は弱いが核酸と結合すると特異的に
螢光強度が増大することに着目し、鋭意研究を行った結
果、幼若化によって増大するDNA (デオキンリポ核
酸)にKB−i反応させ、生ずる螢光強度を測定すれば
、簡単かつ正確に幼若化を測定できることを見出し、本
発明を完成した。
Therefore, the inventors of the present invention set out to overcome this drawback. Ethidium bromide (hereinafter referred to as lf BJ) has weak fluorescence by itself, but when combined with nucleic acids, the fluorescence intensity increases specifically. Focusing on this, as a result of intensive research, we discovered that juvenile development can be easily and accurately measured by reacting KB-i with DNA (deokine liponucleic acid), which increases during juvenile development, and measuring the resulting fluorescence intensity. The present invention has been completed.

従って、本発明は、リンパ球にレクチンを加えて培養し
、次いでこの培養液にF B−Q添加して反応させ、生
ずる螢光強度を測定することを特徴とするレクチン幼若
化測定法である。
Therefore, the present invention provides a method for measuring lectin rejuvenation, which is characterized by adding lectin to lymphocytes and culturing them, then adding F B-Q to this culture solution to cause a reaction, and measuring the resulting fluorescence intensity. be.

試料として使用するリンパ球は、常法、例えばヘパリン
加末梢血をリン酸緩衝液(PBS)等で希釈し、比重遠
心法等によって単核球層を採取することにより調製する
The lymphocytes used as a sample are prepared by a conventional method, for example, by diluting heparinized peripheral blood with phosphate buffered saline (PBS) or the like, and collecting a mononuclear cell layer by specific gravity centrifugation or the like.

レクチンとしては、一般に用いられているものは何れを
も使用でき、例えばフィトヘマグルチニン(PHA)、
ピーナツアグルチニン(PNA)、ソヤビンアグルチニ
ン(SBA)、ホークライードマイト−ジエン(PWM
)、コンカナバリンA (conA)、ウイートジャー
ムアグルチニン(WGA)等が挙げられる。
As the lectin, any commonly used lectin can be used, such as phytohemagglutinin (PHA),
Peanut agglutinin (PNA), soyabin agglutinin (SBA), Hawkelyde mite-diene (PWM)
), concanavalin A (conA), wheat germ agglutinin (WGA), and the like.

リンパ球とレクチンとの培養は通常の方法によって行わ
れる。例えば、培地としてばF(PMエニー64 Q 
、 MEM券を、15 q6 Fe2及びHEPES(
シグマ吐)等で改質した培地等が使用され、リンパ球濃
度は0.5〜1.5 X 10’個/ me、が、まだ
レクチン濃度も常法に従い、例えばPHA−P (DI
FOO社製)の場合0.1〜0.2係程度が好ましい。
Culture of lymphocytes and lectin is performed by a conventional method. For example, as a medium, F (PM any 64 Q
, MEM ticket, 15 q6 Fe2 and HEPES (
A culture medium modified with PHA-P (DI) is used, and the lymphocyte concentration is 0.5 to 1.5
(manufactured by FOO), the ratio is preferably about 0.1 to 0.2.

i@養は約67°Cで72時間程度行うのが好ましい。The i@culture is preferably carried out at about 67°C for about 72 hours.

斯くして得られたレクチン処理リンパ球はラウリル硫酸
ナトリウム(SDS) ’Jを用いて溶解し、これにF
Bを加えて反応させる。このレクチン処理リンパ球(す
なわちこれに含まれるDNA)とFBとの反応条件を検
討した結果は次のとおりである。
The lectin-treated lymphocytes thus obtained were lysed using sodium lauryl sulfate (SDS) 'J, and F
Add B and react. The results of examining the reaction conditions between the lectin-treated lymphocytes (ie, the DNA contained therein) and FB are as follows.

■ KBとDNAの反応時間 EB(6μg/m/PBS) 1mlにD N A [
: Ca1f Thymus(シグマ社)〕浮遊液(5
ttg、/ml PBS ) 1tnlを加えて混和し
、2〜60分間経時的に、分光螢光強度計(日立650
−10)を用いて、螢光強度を測定した。その結果は第
1図のとおりである。これから明らかなように、2〜6
0分ではH! B −DNA 6合体は安定した螢光強
度を示した。従って反応時間は2分以−ヒ、特に10〜
20分が好寸しい。
■ Reaction time of KB and DNA EB (6 μg/m/PBS) DNA [
: Ca1f Thymus (Sigma)] Suspension liquid (5
ttg,/ml PBS) 1tnl was added and mixed, and the spectral fluorescence intensity meter (Hitachi 650
-10), the fluorescence intensity was measured. The results are shown in Figure 1. As is clear from this, 2 to 6
H in 0 minutes! The B-DNA 6 complex showed stable fluorescence intensity. Therefore, the reaction time is 2 minutes or more, especially 10 minutes or more.
20 minutes is a good time.

■ K B 、!r DNへの反応温度E B (6μ
g/ml ) 1 mlにDNA (2,5,5及び1
0 μg/ml ) 1 mlを加えて混和し、4°(
、’IK温及び67°Cで15分間反応させ、■と同様
にして螢光強度を測定した。その結果は第2図のとおり
である。これから明らかな如く、螢光強度は4°C〉室
温〉67°′Cであ之が、6者ともDNA心の増加に伴
い螢光強度は直線的に増加するので、操作中温度を一定
に保持すれば何れの温度でもよいが一般には室温で行う
のが好ましい。
■ K B,! r Reaction temperature to DN E B (6μ
g/ml) DNA (2, 5, 5 and 1
Add 1 ml (0 μg/ml), mix, and shake at 4° (
, 'The reaction was carried out at IK temperature and 67°C for 15 minutes, and the fluorescence intensity was measured in the same manner as in (2). The results are shown in Figure 2. As is clear from this, the fluorescence intensity is 4°C〉room temperature〉67°'C, but in all six cases, the fluorescence intensity increases linearly as the number of DNA hearts increases, so the temperature was kept constant during the operation. Although any temperature may be used as long as the temperature is maintained, it is generally preferable to carry out the reaction at room temperature.

(づ DNA及びEB濃度 1uB(10,7,5及び5μg/mi ) 1 wに
DNA(5〜20μg/me )を加え、室温で15分
間反応させ、■と同様にして螢光強度を測定した。その
結果は第3図のとおりである。これから明らかな如く、
EIJII度が低いほど定量的に測定できる範囲がせま
く、1〜たがって高濃度のDNAを測定する時はEBI
A度を高くするのが好ましい。通常DNA1μgに対し
FBIμg以上使用するのがよい。
DNA and EB concentration 1 uB (10, 7, 5 and 5 μg/mi) DNA (5-20 μg/me) was added to 1 w, reacted for 15 minutes at room temperature, and the fluorescence intensity was measured in the same manner as in ①. The results are shown in Figure 3.As is clear from this,
The lower the EIJII degree, the narrower the range that can be quantitatively measured.
It is preferable to increase the A degree. Generally, it is preferable to use 1 μg of FBI per 1 μg of DNA.

■ 5DS一度 SDS (0,[l 15〜0.5 m9/m1.PB
S) 11nlにKB(6μg /1nl )又はPB
Sllnlを加えて室7MK15分間放置し、■と同様
にして螢光強度を測定した。
■ 5DS once SDS (0, [l 15~0.5 m9/m1.PB
S) KB (6μg/1nl) or PB in 11nl
Sllnl was added and the mixture was left in room 7MK for 15 minutes, and the fluorescence intensity was measured in the same manner as in (2).

その結果は第4図のとおりである。これから明らカナヨ
うに、SDS 0.015〜0.125 ”Gl/ m
e テは、鶏B単独の螢光との差が0.5以下で問題は
ないが、これを超えると光の散乱等が現れ、好ましくな
い。従って5DS一度は0.125+ψ/ rnl以ド
とする。
The results are shown in Figure 4. From now on, it is clear that SDS 0.015~0.125"Gl/m
e Te has no problem if the difference from the fluorescence of Chicken B alone is 0.5 or less, but if it exceeds this, light scattering etc. will appear, which is not preferable. Therefore, 5DS should be less than 0.125+ψ/rnl.

■ F、 Bとリンパ球濃度 リンパ球(0,15〜1.5 X 106個)を5DS
(0,125m97m1 ) 2 dで溶解はせ、これ
にFB(6μg/mz) 1 niを加え、室温で15
分間反応させ、■と同様にして螢光強度を測定した。そ
の結果は第5図のとおりである。これから明らかな如く
、リンパ球をSDS処理しても、前記第3図と同傾向を
示し、これよりDNAの定綾が可能である。
■ F, B and lymphocyte concentration lymphocytes (0.15-1.5 x 106 cells) in 5DS
(0,125m97ml) was dissolved in 2 d, 1 ni of FB (6 μg/mz) was added thereto, and the solution was dissolved at room temperature for 15 ml.
The reaction was allowed to proceed for a minute, and the fluorescence intensity was measured in the same manner as in ①. The results are shown in Figure 5. As is clear from this, even when the lymphocytes were treated with SDS, they showed the same tendency as shown in FIG. 3, and from this, it was possible to conduct constant DNA analysis.

■ 培養時の細胞数の検討 リンパ球濃度0〜4.[] X 106個/m/(I(
PMI−1640)となるように浮遊液を調整し、それ
ぞれをQ、125 % PHA−P (DIFOO社製
)の存在下、又は不存在ドに、67°C172時出1.
5QI)CO2培養器内で培=k I、だ。以下、後S
e実施例(3)と同様にして、E B +SDS+未処
理リンパ球の螢光強度(工、)、li’:B+SDS+
PHA処理リンパ球の螢光強度(工、)及びEB+S 
Df3の螢光強度(工0)を測定した。その結果は第6
図のとおりである。苗、図中、実線(工2− 工o )
の傾きは、後記痺式よりわかる皺に、DNAJli加率
を表わすが、核図より、明らかな如く、リンパ球濃度と
しては、0.5〜1.5X1061固/η21とするの
が好ましい。
■ Examination of cell number during culture Lymphocyte concentration 0-4. [] X 106 pieces/m/(I(
PMI-1640), and each suspension was incubated at 67°C at 172 hours in the presence or absence of Q and 125% PHA-P (manufactured by DIFOO).
5QI) Culture = k I in a CO2 incubator. Below, after S
e In the same manner as in Example (3), E B +SDS+fluorescence intensity of untreated lymphocytes (E), li': B+SDS+
Fluorescence intensity (E) and EB+S of PHA-treated lymphocytes
The fluorescence intensity (work 0) of Df3 was measured. The result is the 6th
As shown in the figure. Seedling, solid line in the figure (Work 2 - Work o)
The slope represents the DNA Jli addition rate in the wrinkles, which can be seen from the paralysis equation described later, but as is clear from the nuclear map, the lymphocyte concentration is preferably 0.5 to 1.5×1061/η21.

以−にのようにして、KB+SDSの螢光強度(Io)
、F、B+SDS+未処理リンパ球の螢光強度(工1)
及びE B + SDS+レクチン処理リンパ球の螢光
強度(■2)を測定し、次の計算式に従ってDNA増加
率を求めることができ、レクチン幼若化を測定すること
ができる。
Fluorescence intensity (Io) of KB+SDS was determined as described above.
, F, B + SDS + fluorescence intensity of untreated lymphocytes (Eng. 1)
The fluorescence intensity (■2) of the lymphocytes treated with E B + SDS + lectin is measured, and the DNA increase rate can be determined according to the following formula, and lectin blastogenesis can be measured.

DNA増加率=I2−Io/工1−■。DNA increase rate = I2-Io/Eq1-■.

叙−4二のり口く、本発明方法ばKBとDNA1j夏合
体の螢光強度を測定する方法であるだめ、測定者による
誤差がなく、しかもリンパ球数による影響も0.5〜1
.5 X 106個/ mlの範囲ではおこらず、更に
操作が簡単である等、従来法に比較し神々の利点を有す
る。
As the method of the present invention measures the fluorescence intensity of KB and DNA1j summer coalescence, there is no error caused by the measuring person, and the influence of the number of lymphocytes is 0.5 to 1.
.. This method has divine advantages over conventional methods, such as not occurring within the range of 5 x 106 cells/ml and being easy to operate.

次に実施例を挙げて説明する。Next, an example will be given and explained.

実施例 (])  ヘパリンカ日末梢血6づに等量のPBSを加
えて混和し、リンパ球分離液による比■遠心法にて単核
球層を取り、PBSで6回洗浄した。これをRPMニー
1640培地に加えてリンパ球が1xio6個/m7!
になるように調整し、リンパ球浮遊液を得た。
Example ()) An equal amount of PBS was added to 6 volumes of heparinized peripheral blood and mixed, and a mononuclear cell layer was collected by specific centrifugation using a lymphocyte separation solution and washed 6 times with PBS. Add this to RPM Nee 1640 medium and get 1xio6 lymphocytes/m7!
A lymphocyte suspension was obtained.

(2)  リンパ球浮遊液0.5yniに0.254 
PHA−P(DIFOO社M ) 0.5 m F’B
s又は上記培地Q、5m1(対照)を加え、24穴平1
底プレート(Nunc社製)に分注し、54 CO2,
67℃で72時間インユベートした。
(2) 0.254 to 0.5yni of lymphocyte suspension
PHA-P (DIFOO M) 0.5 m F'B
Add 5 ml of the above medium Q (control) and add 5 ml of the above medium
Dispense into the bottom plate (manufactured by Nunc) and add 54 CO2,
It was incubated at 67°C for 72 hours.

(3)  プレートポール内の培養リンパ球をピペット
にて、PBBで洗浄しながら試験aに移し、160Or
pmで10分間遠心し、上清を除去した。残渣にSDB
2mef加えてリンパ球を浴解し、これにWS(7) C6fig/m1PBs ) 2 mA!を加え、室温
にて15分間反応させた。この反応液について、分光螢
光強度計(日立、650−60)を用いて、λ]li、
X525nm、 侮x600 nmにて螢光強度を測定
した。同ブランクとしてF B 2d+ SDS 2+
111Jの螢光強度を測定し、前述の計算式に従ってD
NA増加率を求めた。
(3) Using a pipette, transfer the cultured lymphocytes in the plate pole to test a while washing with PBB, and incubate at 160 Or
Centrifugation was performed for 10 minutes at pm, and the supernatant was removed. SDB on residue
Lymphocytes were lysed by adding 2mef, and WS (7) C6fig/m1PBs) 2mA! was added and reacted for 15 minutes at room temperature. Regarding this reaction solution, λ]li,
Fluorescence intensity was measured at x525 nm and x600 nm. FB 2d+ SDS 2+ as the same blank
Measure the fluorescence intensity of 111J and calculate D according to the above formula.
The NA increase rate was determined.

(41+1l−(31のようにして測定した健常人21
例および患者21例のDNA増加率は第7図のとおりで
あった。同患者の疾患名は次のとおりである。
(41+1l-(Healthy person 21 measured as in 31)
The DNA increase rates of the 21 cases and patients were as shown in Figure 7. The patient's disease name is as follows.

(11急性シエローマ、 (2)原発性肝癌、(3)急
性白血病、   (4)サイコイド−シス、(5)悪性
リンパ腫・糖尿病、(6)胛臓癌・肝硬変、(7)肺炎
・呼吸不全、 (8)、(9)肺癌、001、aa食道
癌、   0]1.03前立腺癌、021肺癌・胸膜癌
、Q51.(16)肺結核又は肺炎、OD慢性リューマ
チ、 08)、(21胃癌、a1胛mm、   Qυヘ
ルペス・カルチノーマ
(11 Acute sieroma, (2) Primary liver cancer, (3) Acute leukemia, (4) Psychoidosis, (5) Malignant lymphoma/diabetes, (6) Tumor cancer/liver cirrhosis, (7) Pneumonia/respiratory failure, (8), (9) Lung cancer, 001, aa esophageal cancer, 0] 1.03 prostate cancer, 021 lung cancer/pleural cancer, Q51. (16) Pulmonary tuberculosis or pneumonia, OD chronic rheumatism, 08), (21 gastric cancer, a1胛mm、QυHerpes Carcinoma

【図面の簡単な説明】[Brief explanation of drawings]

第1図はFBとDNAの反応時間と螢光強度との(8) 関係を、7:A2図ばBBとDNAの反応温LWと螢光
強度との関係を、第6図はDNAlA41度と螢光強度
との関係を、第4図はSDS護度と螢光強度との関係を
、第5図はリンパ球のSDS処理による影響を、第6図
は培養時のリンパ球濃度の影響を、第7図は本発明方法
によって測定した健常人と患者のD N A増加率を示
す。 以上 株式会社 日本抗体研究所 第1図 時間(分) 第2図 I)NA倣度(μg/ゴ) 第3図 DNA 濃度(μP//rnz) 第4図 SDS濃度(〜/ml) 第6図    ト→(I −1) 2 0 263− DNA増加率 健       患 常       者 人
Figure 1 shows the relationship (8) between the reaction time of FB and DNA and the fluorescence intensity. Figure 4 shows the relationship between SDS protection and fluorescence intensity, Figure 5 shows the influence of SDS treatment of lymphocytes, and Figure 6 shows the influence of lymphocyte concentration during culture. , FIG. 7 shows the DNA increase rate of healthy subjects and patients measured by the method of the present invention. Figure 1 Time (minutes) Figure 2 I) NA conformity (μg/g) Figure 3 DNA concentration (μP//rnz) Figure 4 SDS concentration (~/ml) Figure 6 Figure → (I-1) 2 0 263- DNA increase rate healthy patients

Claims (1)

【特許請求の範囲】[Claims] 1、リンパ球にレクチンを加えて培養し、次いでその培
養液にエチジウム・ブロマイドを添加して反応はせ、生
ずる螢光強度を測定することを特徴とするレクチン幼若
化測定法。
1. A method for measuring lectin blastogenesis, which comprises adding lectin to lymphocytes and culturing them, then adding ethidium bromide to the culture solution to allow a reaction, and measuring the resulting fluorescence intensity.
JP12327982A 1982-07-15 1982-07-15 Method for measuring lectin juvenilization Pending JPS5913955A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP12327982A JPS5913955A (en) 1982-07-15 1982-07-15 Method for measuring lectin juvenilization

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12327982A JPS5913955A (en) 1982-07-15 1982-07-15 Method for measuring lectin juvenilization

Publications (1)

Publication Number Publication Date
JPS5913955A true JPS5913955A (en) 1984-01-24

Family

ID=14856629

Family Applications (1)

Application Number Title Priority Date Filing Date
JP12327982A Pending JPS5913955A (en) 1982-07-15 1982-07-15 Method for measuring lectin juvenilization

Country Status (1)

Country Link
JP (1) JPS5913955A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63278697A (en) * 1987-04-23 1988-11-16 Nippon Steel Corp Flux cored wire for gas shielded arc welding

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63278697A (en) * 1987-04-23 1988-11-16 Nippon Steel Corp Flux cored wire for gas shielded arc welding

Similar Documents

Publication Publication Date Title
JP3783808B2 (en) Leukocyte classification and counting reagent
Monti et al. Microcalorimetric investigation of cell metabolism in tumour cells from patients with non‐Hodgkin lymphoma (NHL)
Söremark The biological half‐life of bromide ions in human blood
CN102901812A (en) Magnetic particle chemiluminescence immunoassay kit and assay method for human thyroglobulin antibodies (TGAb)
CN102901820A (en) Immunoassay kit and immunodetection method for magnetic particle chemiluminescence of human tumor marker carbohydrate antigen 50 (CA50)
CN103389381A (en) Human epididymal secretory protein E4 chemiluminescence detection kit and preparation method thereof
CN103364558A (en) Human tumor marker carcinoembryonic antigen (CEA) magnetic particle chemiluminiscence immunoassay kit and detection method
CN104698164B (en) A kind of Electrogenerated chemiluminescent immunoassay instrument buffer and preparation method thereof
CN109187971A (en) Neuronspecific enolase chemiluminescence immune detection reagent kit and preparation method thereof
CN109283335A (en) Kit and its preparation method for quantitative detection oophoroma excretion body antigen
CN101231288A (en) Novel method for analyzing human thymidine kinase fluorescence immune based on magnetic nanometer particular
CN101398433A (en) Time-resolved fluorescence immunoassay method fro detecting Dkk-1 and kit thereof
Young et al. The measurement of radioactive sulphur (35S) in biological material
Shwachman et al. Electrical conductivity of sweat: a simple diagnostic test in children
CN107490695B (en) The board-like chemoluminescence method detection kit and preparation method of Carbohydrate Antigen 50
US4039388A (en) Diagnostic test for Niemann-Pick disease
CN106093387A (en) A kind of test kit measuring NBAP
CN107462721B (en) The board-like chemoluminescence method detection kit and preparation method of cytokeratin 19 fragment
CN107167590B (en) The board-like chemoluminescence method detection kit and preparation method of carbohydrate antigen 242
CN108949902A (en) A kind of serum small and dense low-density lipoprotein cholesterin detection reagent box
CN101373188A (en) Tumor-associated antigen 19-9 chemical luminescence immune analytic determination reagent kit and preparation method thereof
JPS5913955A (en) Method for measuring lectin juvenilization
CN102331502B (en) Quantitative measurement kit for human S100 protein (S-100)
CN104730231B (en) A kind of sample buffer for fluorescence immunoassay detection by quantitative and application thereof
CN103116025A (en) Kit for comprehensive detection of gastric cancer by means of time-resolved fluorescence method and application thereof